1 – 2 of 2
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
High dose pollen intralymphatic immunotherapy : Two RDBPC trials question the benefit of dose increase
(
- Contribution to journal › Article
- 2014
-
Mark
LEAP-2, LL-37 and RNase7 in tonsillar tissue: downregulated expression in seasonal allergic rhinitis.
(
- Contribution to journal › Article